Preclinical Evaluation and Monitoring of the Therapeutic Response of a Dual Targeted Hyaluronic Acid Nanodrug

Figure 5

In vivo tumor ablation of HANP/HCPT. (a) Photos of a MDA-MB-231 tumor-bearing mouse model after HANP/HCPT treatment at 0, 3, 7, and 14 days. (b) Growth curve of MDA-MB-231 tumor without treatment and MDA-MB-231 tumor received free HCPT or HANP/HCPT treatments. (c) Survival rate of MDA-MB-231 tumor-bearing mouse model after different treatments. (d) MDA-MB-231 tumor-bearing mouse body weight changes during the study after received different treatment. No obvious changes were found.

(a)

(b)

(c)

(d)